Aardvark Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -10 | -5 | ||
EBITDA | -16,306 | -15,837 | -10,465 | -9,442 |
EBIT | -16,316 | -15,848 | -10,470 | -9,450 |
Net Income | -16,315 | -14,367 | -9,310 | -8,779 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -18,521 | -9,935 | -11,388 | -7,733 |
Cash | 39,285 | 25,998 | 26,504 | 61,641 |
Basic Shares | 21,713 | 21,690 | 13,194 | 12,909 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -16 | -97 | -110 |
EBITDA | -22,652 | -6,653 | -9,764 |
EBIT | -22,668 | -7,415 | -9,874 |
Net Income | -20,588 | -7,208 | -13,564 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -18,196 | -5,824 | -10,543 |
Cash | 61,641 | 9,735 | 15,559 |
Basic Shares | 12,909 | 12,909 | 9,732 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.75 |
2025-06-30 | -$0.66 |
2025-03-31 | -$0.71 |
2024-12-31 | -$0.43 |
